" class="no-js "lang="en-US"> Faeth Therapeutics - Medtech Alert
Saturday, September 20, 2025
Faeth Therapeutics | Pharmtech Focus

Faeth Therapeutics

About Faeth Therapeutics

Faeth Therapeutics

Faeth Therapeutics is a cancer metabolism company developing clinically-tested nutrition control, therapeutics, and digital tools for the treatment of cancer. Founded in 2019 by leading researchers in Europe and the United States and backed by leading investors, the company is pioneering its work in cancer metabolism to support a radically new way to treat cancer. Faeth’s research, published in peer-reviewed scientific journals, shows that tailoring the right diet to the cancer patient can significantly impact the efficacy of clinically tested therapeutics for cancer.

Related Story

Faeth Therapeutics Raises $47 Million to Advance Clinical Trials and Feed the Fight Against Cancer

July 4 2022

Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round […]